Decision letter for "Irisin correlates positively with BMD in a cohort of older adult patients and downregulates the senescent marker p21 in osteoblasts"

2020 ◽  
Keyword(s):  
Older Adult ◽  
Adult Patients

scholarly journals Incidence of and risk factors for postoperative delirium in older adult patients undergoing noncardiac surgery: a prospective study

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Arissara Iamaroon ◽  
Titima Wongviriyawong ◽  
Patumporn Sura-arunsumrit ◽  
Nattikan Wiwatnodom ◽  
Nichakarn Rewuri ◽  
...  
Keyword(s):  
Risk Factors ◽  
Prospective Study ◽  
Older Adult ◽  
Postoperative Delirium ◽  
Noncardiac Surgery ◽  
Adult Patients ◽  
A Prospective Study

Comparison of frailty associated factors between older adult patients with rheumatoid arthritis and community dwellers

2021 ◽  
pp. 104455
Author(s):  
Sae Ozeki ◽  
Kenji Takeuchi ◽  
Mikako Yasuoka ◽  
Koto Kamiji ◽  
Toshihisa Kojima ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Older Adult ◽  
Associated Factors ◽  
Adult Patients ◽  
Community Dwellers

Clinical impact of compound sarcopenia in hospitalized older adult patients with heart failure

2021 ◽  
Author(s):  
Amy Attaway ◽  
Annette Bellar ◽  
Faty Dieye ◽  
Douglas Wajda ◽  
Nicole Welch ◽  
...  
Keyword(s):  
Heart Failure ◽  
Older Adult ◽  
Clinical Impact ◽  
Adult Patients ◽  
Patients With Heart Failure

scholarly journals Involvement of Irisin in age-related osteoporosis: positive correlation with BMD in older adult patients and inhibitory effect on the senescent marker p21 in osteoblasts

Bone Reports ◽  
2021 ◽  
Vol 14 ◽  
pp. 100833
Author(s):  
Graziana Colaianni ◽  
Lorenzo Sanesi ◽  
Giuseppina Storlino ◽  
Roberta Zerlotin ◽  
Patrizia Pignataro ◽  
...  
Keyword(s):  
Older Adult ◽  
Inhibitory Effect ◽  
Adult Patients ◽  
Positive Correlation ◽  
Age Related

Complete congenital stationary night blindness associated with a novel NYX variant (p.Asn216Lys) in middle-aged and older adult patients

2021 ◽  
pp. 1-8
Author(s):  
Takaaki Hayashi ◽  
Yusuke Murakami ◽  
Kei Mizobuchi ◽  
Yoshito Koyanagi ◽  
Koh-Hei Sonoda ◽  
...  
Keyword(s):  
Older Adult ◽  
Night Blindness ◽  
Adult Patients ◽  
Congenital Stationary Night Blindness ◽  
Middle Aged

scholarly journals Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting

2019 ◽  
Vol 15 (1) ◽  
pp. e30-e38 ◽  
Author(s):  
Allison Lipitz-Snyderman ◽  
Coral L. Atoria ◽  
Stephen M. Schleicher ◽  
Peter B. Bach ◽  
Katherine S. Panageas
Keyword(s):  
Older Adult ◽  
Advanced Cancer ◽  
Odds Ratio ◽  
Hierarchical Modeling ◽  
Outpatient Setting ◽  
Adult Patients ◽  
Medicare Beneficiaries ◽  
Hospital Outpatient ◽  
Outpatient Departments ◽  
Retrospective Comparative Study

PURPOSE: A shift in outpatient oncology care from the physician’s office to hospital outpatient settings has generated interest in the effect of practice setting on outcomes. Our objective was to examine whether medical oncologists’ prescribing of drugs and services for older adult patients with advanced cancer is used more in physicians’ offices compared with hospital outpatient departments. METHODS: This was a retrospective comparative study. SEER-Medicare data (2004 to 2011) were used to identify Medicare beneficiaries diagnosed with advanced breast, colon, esophagus, non–small-cell lung, pancreatic, or stomach cancer. Between physicians’ offices and hospital outpatient departments, we compared use of selected likely low-value supportive drugs, low-value therapeutic drugs, chemotherapy-related hospitalizations, and hospice. We used hierarchical modeling to assess differences between settings to account for correlation within physicians. RESULTS: Compared with patients treated in a hospital outpatient department, those treated in a physician’s office setting were more likely to receive erythropoiesis-stimulating agents (odds ratio, 1.72; 95% CI, 1.53 to 1.94) and granulocyte colony–stimulating factors (odds ratio, 1.28; 95% CI, 1.18 to 1.38). For combination chemotherapy and nanoparticle albumin-bound–paclitaxel in patients with breast cancer, there was a trend toward higher use in physicians’ offices, although this was not statistically significant. Chemotherapy-related hospitalizations and hospice did not vary by setting. CONCLUSION: We found somewhat higher use of several drugs for patients with advanced cancer in physicians’ office settings compared with hospital outpatient departments. Findings support research to dissect the mechanisms through which setting might influence physicians’ behavior.

Sign in / Sign up

Export Citation Format

Share Document